Zimmer Biomet Holdings Inc
NYSE:ZBH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
101.77
132.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zimmer Biomet Holdings Inc
Wall Street
Price Targets
ZBH Price Targets Summary
Zimmer Biomet Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ZBH
is 126.52 USD
with a low forecast of 108.07 USD and a high forecast of 147 USD.
ZBH Last Price Targets
Zimmer Biomet Holdings Inc
The latest public price target was made on Oct 31, 2024 by
Richard Newitter
from
Truist Financial
,
who expects
ZBH
stock to
rise by 9%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
Operating Income
Forecast
Operating Income Estimate
Zimmer Biomet Holdings Inc
For the last 8 years the
compound annual growth rate for
Zimmer Biomet Holdings Inc's operating income is
2%.
The projected
CAGR
for the next 4 years is
15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZBH's stock price target?
Price Target
126.52
USD
According to Wall Street analysts, the average 1-year price target for
ZBH
is 126.52 USD
with a low forecast of 108.07 USD and a high forecast of 147 USD.
What is Zimmer Biomet Holdings Inc's Revenue forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Zimmer Biomet Holdings Inc's revenue is
3%.
The projected
CAGR
for the next 4 years is
4%.
What is Zimmer Biomet Holdings Inc's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Zimmer Biomet Holdings Inc's operating income is
2%.
The projected
CAGR
for the next 4 years is
15%.
What is Zimmer Biomet Holdings Inc's Net Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Zimmer Biomet Holdings Inc's net income is
27%.
The projected
CAGR
for the next 4 years is
18%.
You don't have any saved screeners yet
